HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MDR-TB Management Group Selected Research

bedaquiline (R207910)

1/2022Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


MDR-TB Management Group Research Topics

Disease

1Extensively Drug-Resistant Tuberculosis
01/2022

Drug/Important Bio-Agent (IBA)

1bedaquiline (R207910)IBA
01/2022
1Linezolid (Zyvox)FDA Link
01/2022
1FluoroquinolonesIBA
01/2022